Search - tctmd.com

Displaying 41 - 60 of 342

Sort: Relevancy | Date

Presentation TCT 2023

First-in-Man Intravascular Fluorescence Lifetime ImaGing for Highly-Sensitive Molecular Characterization of Coronary AtheromaTa (FLIGHT Trial)

Presenter: Jin Won Kim

October 26, 2023

Presentation TCT 2023

Optical Coherence Tomography-based Functional Stenosis Assessment: FUSION - A Prospective Multi-Center Trial

Presenter: Allen Jeremias

October 26, 2023

Presentation TCT 2023

An Optical Coherence Tomography Guided Non-Stenting Reperfusion Strategy in Patients with STEMI— A Prospective, Multi-Centre, Observational Study (EROSION II)

Presenter: Haibo Jia

October 26, 2023

Presentation TCT 2023

First-in-Human Experience with the Novel Watchman FLX Pro Device: Results of the Watchman FLX Pro CT study

Presenter: Jens Erik Nielsen-Kudsk

October 25, 2023

Presentation TCT 2023

US Early Feasibility Study Evaluating the Safety and Efficacy of Rotational Closure of the Left Atrial Appendage Using the Laminar Device in Patients with Non-Valvular Atrial Fibrillation

Presenter: Saibal Kar

October 25, 2023

Presentation TCT 2023

Percutaneous Left Atrial Appendage Closure Versus Chronic Oral Anticoagulation for Non-Valvular Atrial Fibrillation: An Individual Patient Data Level Meta-Analysis of Randomized Controlled Trials

Presenter: Yousif Ahmad

October 25, 2023

Presentation TCT 2023

Histomorphometric and Histopathologic Findings in Patients Undergoing Left Atrial Appendage Closure With Use of a Double-Filter Embolic Protection Device

Presenter: Julia Seeger

October 25, 2023

Presentation TCT 2023

Keynote Lecture: Which Anticoagulant or Antiplatelet Regimen Post LAAO - The Present and Future?

Presenter: Sanjit Jolly

October 25, 2023

Presentation TCT 2023

A Novel Single-Leaflet Tricuspid Valve Replacement System (Trisol): Early Clinical Results

Presenter: Isaac George

October 25, 2023

Presentation TCT 2023

One-Month Outcomes of the Multicenter TRAVEL II (Transvascular Tricuspid Valve Replacement with the LuX-Valve Plus System) Study

Presenter: Junbo Ge

October 25, 2023

Presentation TCT 2023

A Novel Heterotopic Tricuspid Regurgitation Device for the Treatment of Tricuspid Regurgitation (Innoventric)

Presenter: Philipp Lurz

October 25, 2023

Presentation TCT 2023

The CROIVALVE Duo System for the Percutaneous Treatment of Tricuspid Regurgitation: Technology and Program Update

Presenter: Adam Witkowski

October 25, 2023

Presentation TCT 2023

First-in-Human Experience with a Tricuspid Valve Flow Optimizer (TriFlow)

Presenter: Gorav Ailawadi

October 25, 2023

Presentation TCT 2023

Safety and Efficacy of a Novel Vertical Spacer with Atraumatic Anchoring for Tricuspid Regurgitation: A First-in-Man Experience (Pivot Bridge)

Presenter: Joo-Yong Hahn

October 25, 2023

Presentation TCT 2023

TRILUMINATE Pivotal Imaging Substudy: Insights from CT and MRI

Presenter: Joao Cavalcante

October 25, 2023

Presentation TCT 2023

Validation of the Kansas City Cardiomyopathy Questionnaire in Patients With Tricuspid Regurgitation: The Tri-QOL Study

Presenter: Suzanne Arnold

October 25, 2023

Presentation TCT 2023

Long-term Clinical Outcomes After iFR vs. FFR Guided Coronary Revascularization – Insights From the SWEDEHEART National Registry

Presenter: Matthias Götberg

October 25, 2023

Presentation TCT 2023

TCT 244: Impact of Online Educational Series on Interventional Innovations in Blood Pressure Control

Presenter: Ron miller

October 25, 2023

Presentation TCT 2023

Long-Term Outcomes with Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: 5-Year Follow-up of the Biostemi Randomized Trial

Presenter: Juan Iglesias

October 25, 2023

Presentation TCT 2023

Polymer-Free Amphilimus-Eluting Stents vs. Biodegradable-Polymer Everolimus-Eluting Stents in All-Comers Undergoing PCI: 1-Year Results of the PARTHENOPE Trial

Presenter: Giovanni Esposito

October 25, 2023

Advertisement

First-in-Man Intravascular Fluorescence Lifetime ImaGing for Highly-Sensitive Molecular Characterization of Coronary AtheromaTa (FLIGHT Trial)

Optical Coherence Tomography-based Functional Stenosis Assessment: FUSION - A Prospective Multi-Center Trial

An Optical Coherence Tomography Guided Non-Stenting Reperfusion Strategy in Patients with STEMI— A Prospective, Multi-Centre, Observational Study (EROSION II)

First-in-Human Experience with the Novel Watchman FLX Pro Device: Results of the Watchman FLX Pro CT study

US Early Feasibility Study Evaluating the Safety and Efficacy of Rotational Closure of the Left Atrial Appendage Using the Laminar Device in Patients with Non-Valvular Atrial Fibrillation

Percutaneous Left Atrial Appendage Closure Versus Chronic Oral Anticoagulation for Non-Valvular Atrial Fibrillation: An Individual Patient Data Level Meta-Analysis of Randomized Controlled Trials

Histomorphometric and Histopathologic Findings in Patients Undergoing Left Atrial Appendage Closure With Use of a Double-Filter Embolic Protection Device

Keynote Lecture: Which Anticoagulant or Antiplatelet Regimen Post LAAO - The Present and Future?

A Novel Single-Leaflet Tricuspid Valve Replacement System (Trisol): Early Clinical Results

One-Month Outcomes of the Multicenter TRAVEL II (Transvascular Tricuspid Valve Replacement with the LuX-Valve Plus System) Study

A Novel Heterotopic Tricuspid Regurgitation Device for the Treatment of Tricuspid Regurgitation (Innoventric)

The CROIVALVE Duo System for the Percutaneous Treatment of Tricuspid Regurgitation: Technology and Program Update

First-in-Human Experience with a Tricuspid Valve Flow Optimizer (TriFlow)

Safety and Efficacy of a Novel Vertical Spacer with Atraumatic Anchoring for Tricuspid Regurgitation: A First-in-Man Experience (Pivot Bridge)

TRILUMINATE Pivotal Imaging Substudy: Insights from CT and MRI

Validation of the Kansas City Cardiomyopathy Questionnaire in Patients With Tricuspid Regurgitation: The Tri-QOL Study

Long-term Clinical Outcomes After iFR vs. FFR Guided Coronary Revascularization – Insights From the SWEDEHEART National Registry

TCT 244: Impact of Online Educational Series on Interventional Innovations in Blood Pressure Control

Long-Term Outcomes with Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: 5-Year Follow-up of the Biostemi Randomized Trial

Polymer-Free Amphilimus-Eluting Stents vs. Biodegradable-Polymer Everolimus-Eluting Stents in All-Comers Undergoing PCI: 1-Year Results of the PARTHENOPE Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content